Therefore, tumorigenic EMT seems to be promoted by a reciprocal immunosuppressive interplay between tumor cells and macrophages, activated by IL-6/JAK/STAT3 signaling during the early phases of tumor progression [55]. This evidence concerns the gene IL6 and neoplasm.